Biotech bigwig Gilead Sciences Inc. GILDdevelops drugs for the treatment of human immunodeficiency virus (“HIV”), liver diseases such as chronic hepatitis C virus (“HCV”) infection and chronic hepatitis B virus (“HBV”) infection, cardiovascular, hematology/oncology and inflammation/respiratory diseases.
HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться